We recently demonstrated that MuvB-B-MYB is required for tumorigenesis in vivo in a mouse model of lung cancer and that deletion of B-MYB or of the LIN9 subunit MuvB inhibited lung tumor formation driven by oncogenic K-RAS and loss of p53 [22]. Here, MYBL2 is linked to lung carcinoma.